Particle.news
Download on the App Store

Ardent Health Hit With Securities Class Action Over Receivables and Reserve Disclosures

Investors have until March 9, 2026 to seek appointment as lead plaintiff.

Overview

  • The case, Postiwala v. Ardent Health, Inc., No. 3:26-cv-00022, is pending in the U.S. District Court for the Middle District of Tennessee.
  • The proposed class covers investors who bought Ardent Health securities from July 18, 2024 through November 12, 2025.
  • Plaintiffs allege Ardent misrepresented its accounts receivable process by touting detailed hindsight reviews while using a 180‑day cliff to fully reserve accounts.
  • Disclosures on November 12, 2025 included a ~$43 million revenue reduction tied to the new Kodiak RCA system, a ~$54 million increase in professional liability reserves, and a cut to 2025 EBITDA guidance.
  • Ardent shares fell about 33% on November 13, 2025, and multiple firms are recruiting class members as Hagens Berman also investigates potential internal-control weaknesses.